Listen Now
Topics Covered
- HER2-Positive Metastatic Breast Cancer
- Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New & Emerging Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials
- How Research Contributes to Your Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
- Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts
![Presenter](https://media.cancercare.org/people/headshots/original/Julie-Fisher-24.png)
Julie G. Fisher, MD
Medical Director, Levine Cancer Institute, Co-Director, Sandra Levine Young Women’s Breast Cancer Program, Associate Hematology/Oncology Fellowship Director, Levine Cancer Institute
![Presenter](https://media.cancercare.org/people/headshots/original/Dame-Idossa-24.png)
Dame Idossa, MD
Assistant Professor of Medicine, Breast Oncologist, Division of Hematology and Oncology, University of Minnesota
![Presenter](https://media.cancercare.org/people/headshots/original/Dr.-Shimoli-V.-Barot.jpg)
Shimoli V. Barot, MD
Associate Staff, Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Center
![Presenter](https://media.cancercare.org/people/headshots/original/headshot.jpg)
Saba Shaikh, MD
Assistant Professor, Division of Hematology/Oncology, Mays Cancer Center at UT Health San Antonio, MD Anderson Cancer Center
![Presenter](https://media.cancercare.org/people/headshots/original/CancerCare_Spector_Cassie.jpg)
Cassie Spector, MSW
Breast and Gynecological Cancers Program Coordinator, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on April 24, 2024.